LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Lista de Ações・NeoGenomics Inc

NeoGenomics Inc

Fechado

9.23 1.54

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

9.19

Máximo

9.25

Indicadores-chave
By Trading Economics
Rendimento	-7.2M -17M
Vendas	-3.5M 187M
EPS	0.01
Margem de lucro	-9.164
Funcionários	2,500
EBITDA	-5.8M -567K

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+61.76% upside

Dividendos
By Dow Jones
Próximos Ganhos	28 de jul. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-31M 1.1B
Abertura anterior	7.69
Fecho anterior	9.23

NeoGenomics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de mai. de 2026, 18:09 UTC

Conversa de Mercado

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 de mai. de 2026, 16:54 UTC

Conversa de Mercado

Crypto Spot Volumes Fall 14% in April -- Market Talk

22 de mai. de 2026, 14:53 UTC

Conversa de Mercado

USDT Build on Binance May Signal Refreshed Crypto Appetite -- Market Talk

22 de mai. de 2026, 11:51 UTC

Conversa de Mercado

Bitcoin Dented by U.S. Rate-Rise Bets, Iran War Uncertainty -- Market Talk

22 de mai. de 2026, 07:28 UTC

Conversa de Mercado

Bitcoin Falls as Investors Weigh Conflicting Iran War Headlines -- Market Talk

21 de mai. de 2026, 17:04 UTC

Conversa de Mercado

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21 de mai. de 2026, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

21 de mai. de 2026, 16:08 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

21 de mai. de 2026, 16:08 UTC

Conversa de Mercado

Zcash Backtracks After Yesterday's Surge -- Market Talk

21 de mai. de 2026, 15:39 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

21 de mai. de 2026, 15:39 UTC

Conversa de Mercado

Hyperliquid ETFs Gaining Momentum as Price Soars -- Market Talk

21 de mai. de 2026, 13:52 UTC

Conversa de Mercado

Bitcoin Shows Signs of Repeating 2022 Trading Pattern -- Market Talk

21 de mai. de 2026, 07:03 UTC

Conversa de Mercado

Bitcoin Falls on Iran War Uncertainty, U.S. Rate Rise Bets -- Market Talk

20 de mai. de 2026, 17:08 UTC

Conversa de Mercado

Zcash Benefiting From Investments in 'Production-Grade Privacy' -- Market Talk

20 de mai. de 2026, 16:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

20 de mai. de 2026, 15:51 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

20 de mai. de 2026, 15:51 UTC

Conversa de Mercado

Zcash Tears Higher in Mostly Positive Day for Crypto -- Market Talk

20 de mai. de 2026, 15:39 UTC

Conversa de Mercado

Bitcoin Support Seen as $76k, Says Bitfinex -- Market Talk

20 de mai. de 2026, 13:08 UTC

Conversa de Mercado

Bitcoin Rangebound as ETF Outflows Continue -- Market Talk

20 de mai. de 2026, 12:44 UTC

Conversa de Mercado

Bitcoin Gains Slightly as U.S. Stock Futures Rise -- Market Talk

20 de mai. de 2026, 07:25 UTC

Conversa de Mercado

Bitcoin Edges Higher But Iran War Uncertainty Limits Gains -- Market Talk

19 de mai. de 2026, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

19 de mai. de 2026, 15:54 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 de mai. de 2026, 15:54 UTC

Conversa de Mercado

Bitcoin Holders Under Little Pressure to Sell Despite ETF Outflow -- Market Talk

19 de mai. de 2026, 14:51 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 de mai. de 2026, 14:51 UTC

Conversa de Mercado

Ethereum Down From Near-Term High -- Market Talk

19 de mai. de 2026, 08:26 UTC

Conversa de Mercado

Bitcoin Edges Higher as Oil Price, Bond Yields Fall -- Market Talk

19 de mai. de 2026, 08:26 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

18 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

18 de mai. de 2026, 17:22 UTC

Conversa de Mercado

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

Comparação entre Pares

Variação de preço

NeoGenomics Inc Previsão

Preço-alvo

By TipRanks

61.76% parte superior

Previsão para 12 meses

Média 14.93 USD 61.76%

Máximo 25 USD

Mínimo 11 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para NeoGenomics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

10 ratings

Comprar

Manter

Vender

Com base em 10 analistas que deram avaliações de ações para NeoGenomics Inc - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.